Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Midatech Pharma Ads (MTP)

Midatech Pharma Ads (MTP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,194
  • Shares Outstanding, K 12,610
  • Annual Sales, $ 860 K
  • Annual Income, $ -12,880 K
  • 60-Month Beta 2.87
  • Price/Sales 25.04
  • Price/Cash Flow N/A
  • Price/Book 1.98

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6000 +10.00%
on 09/24/20
2.5400 -30.71%
on 08/28/20
-0.5800 (-24.79%)
since 08/25/20
3-Month
1.2500 +40.80%
on 07/14/20
7.0700 -75.11%
on 07/21/20
+0.3300 (+23.08%)
since 06/25/20
52-Week
0.8620 +104.18%
on 03/18/20
8.5000 -79.29%
on 10/02/19
-4.3480 (-71.19%)
since 09/25/19

Most Recent Stories

More News
Midatech Pharma PLC Announces Interim results - 6 months ended 30 June 2020

MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Interim results - 6 months ended 30 June 2020

MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Investor Webinar

ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 7, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines,...

MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Notice of Interim Results

Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, will announce its interim results for the six months...

MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Exercise of Warrants and Issue of Equity

Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it has issued to certain US investors...

LNSTY : 28.3300 (unch)
MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Registration Statement Declared Effective

Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that the U.S. Securities and Exchange...

LNSTY : 28.3300 (unch)
MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Grant of Options

Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces that options over a total of 1,401,000...

MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Results for the year ended 31 December 2019

MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Purported Termination of MTX110 Licence Agreement

LNSTY : 28.3300 (unch)
MTP : 1.7600 (+2.92%)
Midatech Pharma PLC Announces Research collaboration with Dr Reddy's

LNSTY : 28.3300 (unch)
MTP : 1.7600 (+2.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MTP with:

Business Summary

Midatech Pharma Plc is focused on the discovery and development of pharmaceutical products of nanomedicine. The Company's product candidates, which are in clinical and pre-clinical development, are Transbuccal Insulin, glucagon-like-peptide, GLP-1/Insulin Combination, Q-Exenatide and Q-Octreotide. Midatech...

See More

Key Turning Points

2nd Resistance Point 1.9000
1st Resistance Point 1.8300
Last Price 1.7600
1st Support Level 1.6700
2nd Support Level 1.5800

See More

52-Week High 8.5000
Fibonacci 61.8% 5.5823
Fibonacci 50% 4.6810
Fibonacci 38.2% 3.7797
Last Price 1.7600
52-Week Low 0.8620

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar